AU2003254375B2 - Method for purifying preproinsulin - Google Patents

Method for purifying preproinsulin Download PDF

Info

Publication number
AU2003254375B2
AU2003254375B2 AU2003254375A AU2003254375A AU2003254375B2 AU 2003254375 B2 AU2003254375 B2 AU 2003254375B2 AU 2003254375 A AU2003254375 A AU 2003254375A AU 2003254375 A AU2003254375 A AU 2003254375A AU 2003254375 B2 AU2003254375 B2 AU 2003254375B2
Authority
AU
Australia
Prior art keywords
gly
leu
ser
cys
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003254375A
Other languages
English (en)
Other versions
AU2003254375A1 (en
Inventor
Hans Blumenstock
Chantalle Havenith
Horst Thurow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of AU2003254375A1 publication Critical patent/AU2003254375A1/en
Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH
Application granted granted Critical
Publication of AU2003254375B2 publication Critical patent/AU2003254375B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AU2003254375A 2002-08-01 2003-07-18 Method for purifying preproinsulin Ceased AU2003254375B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10235168A DE10235168A1 (de) 2002-08-01 2002-08-01 Verfahren zur Reinigung von Preproinsulin
DE10235168.6 2002-08-01
PCT/EP2003/007820 WO2004013176A1 (de) 2002-08-01 2003-07-18 Verfahren zur reinigung von preproinsulin

Publications (2)

Publication Number Publication Date
AU2003254375A1 AU2003254375A1 (en) 2004-02-23
AU2003254375B2 true AU2003254375B2 (en) 2009-01-08

Family

ID=30128614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003254375A Ceased AU2003254375B2 (en) 2002-08-01 2003-07-18 Method for purifying preproinsulin

Country Status (16)

Country Link
US (2) US20050080000A1 (cg-RX-API-DMAC7.html)
EP (1) EP1527097B1 (cg-RX-API-DMAC7.html)
JP (1) JP4519646B2 (cg-RX-API-DMAC7.html)
AT (1) ATE384742T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003254375B2 (cg-RX-API-DMAC7.html)
BR (1) BR0313131A (cg-RX-API-DMAC7.html)
CA (1) CA2493539C (cg-RX-API-DMAC7.html)
CY (1) CY1108046T1 (cg-RX-API-DMAC7.html)
DE (2) DE10235168A1 (cg-RX-API-DMAC7.html)
DK (1) DK1527097T3 (cg-RX-API-DMAC7.html)
ES (1) ES2297223T3 (cg-RX-API-DMAC7.html)
IL (1) IL166438A (cg-RX-API-DMAC7.html)
MX (1) MXPA05001042A (cg-RX-API-DMAC7.html)
PT (1) PT1527097E (cg-RX-API-DMAC7.html)
SI (1) SI1527097T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004013176A1 (cg-RX-API-DMAC7.html)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
ES2395096T3 (es) * 1999-06-29 2013-02-08 Mannkind Corporation Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
US7338171B2 (en) * 2003-10-27 2008-03-04 Jen-Chuen Hsieh Method and apparatus for visual drive control
US20050153874A1 (en) * 2004-01-12 2005-07-14 Mannkind Corporation Method of reducing serum proinsulin levels in type 2 diabetics
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
US20070086952A1 (en) * 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
WO2007121256A2 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
WO2009089181A1 (en) * 2008-01-04 2009-07-16 Blodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
PH12011502708B1 (en) 2009-07-06 2017-11-10 Sanofi Aventis Deutschland Insulin preparations containing methionine
PL2464655T3 (pl) * 2009-08-11 2017-08-31 Biocon Limited Procesy chromatograficzne
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
AU2012213432B2 (en) 2011-02-01 2016-10-13 Novo Nordisk A/S Purification of insulin
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
CN102219851B (zh) * 2011-05-09 2012-05-30 甘李药业有限公司 甘精胰岛素结晶的制备方法
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CA2954287C (en) * 2014-07-08 2020-12-22 Amphastar Pharmaceuticals, Inc. Methods of preparing inhalable micronized insulin for pulmonary delivery
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
CN113773392B (zh) * 2020-06-09 2023-04-07 宁波鲲鹏生物科技有限公司 一种甘精胰岛素的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
CA1339955C (en) 1986-10-14 1998-07-14 Richard Eugene Heiney Process for transforming a human insulin precursor to human insulin
JPH0832726B2 (ja) * 1987-06-08 1996-03-29 武田薬品工業株式会社 ラットbFGFおよびその製造法
DE3726655A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
JP2916206B2 (ja) * 1990-04-28 1999-07-05 帝國製薬株式会社 生理活性ペプチド
SG46612A1 (en) * 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
DE19947456A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh
DE10008064B4 (de) * 2000-02-22 2009-07-02 Siemens Ag Verfahren zum Anpassen der einem Turbo-Codierer zuzuführenden Datenblöcke und entsprechende Kommunikationsvorrichtung

Also Published As

Publication number Publication date
DK1527097T3 (da) 2008-05-26
ATE384742T1 (de) 2008-02-15
CA2493539C (en) 2012-01-31
US7803763B2 (en) 2010-09-28
BR0313131A (pt) 2005-07-05
US20060183666A1 (en) 2006-08-17
ES2297223T3 (es) 2008-05-01
DE50309087D1 (cg-RX-API-DMAC7.html) 2008-03-13
JP2006513978A (ja) 2006-04-27
CA2493539A1 (en) 2004-02-12
JP4519646B2 (ja) 2010-08-04
EP1527097A1 (de) 2005-05-04
AU2003254375A1 (en) 2004-02-23
IL166438A0 (en) 2006-01-15
CY1108046T1 (el) 2013-09-04
PT1527097E (pt) 2008-02-25
IL166438A (en) 2010-11-30
SI1527097T1 (sl) 2008-04-30
MXPA05001042A (es) 2005-04-08
US20050080000A1 (en) 2005-04-14
EP1527097B1 (de) 2008-01-23
DE10235168A1 (de) 2004-02-12
WO2004013176A1 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
CA2493539C (en) A method for purifying preproinsulin
KR100574580B1 (ko) 정확하게 결합된 시스틴 브릿지를 갖는 인슐린 또는 인슐린유도체를 수득하는 방법
RU2037500C1 (ru) Способ очистки инсулина и/или его производных
JP4975895B2 (ja) 高圧液体クロマトグラフィーによるインシュリンの単離方法
CN110526982B (zh) 一种人胰高血糖素样肽-1类似物融合蛋白的纯化方法
JPH06505010A (ja) 正確にフォールドされた完全なインスリン様成長因子−1の精製方法
JPH07265092A (ja) 正しく連結されたシスチン架橋を有するインシュリンを得る方法
EP2813514A1 (en) Method for purifying solid-phase synthetic crude liraglutide
Markussen et al. Immobilized insulin for high capacity affinity chromatography of insulin receptors.
WO2016144658A1 (en) Process for preparing recombinant insulin using microfiltration
US5621073A (en) Chromatographic process for purification of insulin
DE69120409T2 (de) Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte
US6906183B2 (en) Process for the separation of glycosylated and nonglycosylated proteins
RU2081122C1 (ru) Способ выделения и очистки инсулина или его биотехнологических предшественников
WO2017040363A1 (en) A process for obtaining insulin with correctly formed disulfide bonds
CN114324669B (zh) 一种鲑鱼促性腺激素释放激素类似物中l-精氨酸残留量的柱前手性衍生测定方法
CN113984911B (zh) 一种同时分析利拉鲁肽及其Boc-利拉鲁肽主链的色谱方法
WO2004048588A1 (en) Process for purifying a fermentation-derived product
RU2126690C1 (ru) Способ очистки инсулина-сырца, получаемого из поджелудочной железы свиней
KR100341297B1 (ko) 재조합활성형프로인슐린의분리.정제방법
CA3018627C (en) Purification of glucagon-like peptide 1 analogs
CA3018627A1 (en) Purification of glucagon-like peptide 1 analogs
HK1010457B (en) Process to obtain insulin with correct cystin bridges

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: FORMER APPLICANT(S): AVENTIS PHARMA DEUTSCHLAND GMBH

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired